Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.
Saved in:
| Title: | Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial. |
|---|---|
| Authors: | Chew KW; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Taiwo BO; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Moser C; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Daar ES; Lundquist Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, California, USA., Wohl DA; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ritz J; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Javan AC; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Li JZ; Department of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA., Fischer W; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Greninger AL; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA., Bausch C; SAB Biotherapeutics, Inc, Sioux Falls, South Dakota, USA., Luke T; SAB Biotherapeutics, Inc, Sioux Falls, South Dakota, USA., Call R; Clinical Research Partners, Richmond, Virginia, USA., Neytman G; Quantum Clinical Trials, Miami, Florida, USA., Giganti MJ; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Fletcher CV; Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA., Hughes MD; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Eron JJ; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Currier JS; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Smith DM; Department of Medicine, University of California, San Diego, La Jolla, California, USA. |
| Corporate Authors: | ACTIV-2/A5401 Study Team |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1177-1186. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39028902 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chew+KW%22">Chew KW</searchLink>; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Taiwo+BO%22">Taiwo BO</searchLink>; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Moser+C%22">Moser C</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Daar+ES%22">Daar ES</searchLink>; Lundquist Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Wohl+DA%22">Wohl DA</searchLink>; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Ritz+J%22">Ritz J</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Javan+AC%22">Javan AC</searchLink>; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Li+JZ%22">Li JZ</searchLink>; Department of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Fischer+W%22">Fischer W</searchLink>; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Greninger+AL%22">Greninger AL</searchLink>; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bausch+C%22">Bausch C</searchLink>; SAB Biotherapeutics, Inc, Sioux Falls, South Dakota, USA.<br /><searchLink fieldCode="AU" term="%22Luke+T%22">Luke T</searchLink>; SAB Biotherapeutics, Inc, Sioux Falls, South Dakota, USA.<br /><searchLink fieldCode="AU" term="%22Call+R%22">Call R</searchLink>; Clinical Research Partners, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Neytman+G%22">Neytman G</searchLink>; Quantum Clinical Trials, Miami, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Giganti+MJ%22">Giganti MJ</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Fletcher+CV%22">Fletcher CV</searchLink>; Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+MD%22">Hughes MD</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Eron+JJ%22">Eron JJ</searchLink>; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Currier+JS%22">Currier JS</searchLink>; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Smith+DM%22">Smith DM</searchLink>; Department of Medicine, University of California, San Diego, La Jolla, California, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ACTIV-2%2FA5401+Study+Team%22">ACTIV-2/A5401 Study Team</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1177-1186. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39028902 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiae369 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1177 Titles: – TitleFull: Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chew KW – PersonEntity: Name: NameFull: Taiwo BO – PersonEntity: Name: NameFull: Moser C – PersonEntity: Name: NameFull: Daar ES – PersonEntity: Name: NameFull: Wohl DA – PersonEntity: Name: NameFull: Ritz J – PersonEntity: Name: NameFull: Javan AC – PersonEntity: Name: NameFull: Li JZ – PersonEntity: Name: NameFull: Fischer W – PersonEntity: Name: NameFull: Greninger AL – PersonEntity: Name: NameFull: Bausch C – PersonEntity: Name: NameFull: Luke T – PersonEntity: Name: NameFull: Call R – PersonEntity: Name: NameFull: Neytman G – PersonEntity: Name: NameFull: Giganti MJ – PersonEntity: Name: NameFull: Fletcher CV – PersonEntity: Name: NameFull: Hughes MD – PersonEntity: Name: NameFull: Eron JJ – PersonEntity: Name: NameFull: Currier JS – PersonEntity: Name: NameFull: Smith DM IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2024 Nov 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 230 – Type: issue Value: 5 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |